Navigation Links
Biodel Appoints Arthur Urciuoli to its Board of Directors
Date:9/17/2010

s, including, but not limited to, our ability to secure FDA approval for Linjeta(TM) and our other product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel(TM) technology, particularly Linjeta(TM) the progress or success of our research, development and clinical programs and the initiation and completion of our clinical trials; the FDA's findings regarding data anomalies observed in India in our Phase 3 clinical trial of Linjeta(TM) for patients with Type 1 diabetes; the possibility that patients taking Linjeta(TM) may experience more injection site discomfort than they experience with competing products; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our most recent quarterly report on Form 10-Q for the quarter ended June 30, 2010. The company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.Contact:The Trout Group LLCSeth D. Lewis, +1-646-378-2952
'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
2. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
3. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
4. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
5. Biodel to Raise $9.4 Million Through Registered Direct Offering
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. West Pharmaceutical Services, Inc. Appoints New Director
8. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
9. Curemark Appoints Preeminent Pediatrics Gastroenterologist
10. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
11. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Reportlinker.com announces that a new market ... Global Heart Valve Repair and Replacement Market ... About Heart Valve Repair and Replacement Heart ... control the flow of blood during the cardiac ... such as valvular stenosis, valvular insufficiency or regurgitation, ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
(Date:8/27/2014)... 27, 2014 Pulse Systems, Inc. , an ... Practice Management , and Revenue Cycle Management (RCM) solutions ... performed by some RCM vendors, at UBM Medica,s Practice ... on September 19-20, 2014.  A presenter at ... September with a new session encouraging practices to "Look before ...
Breaking Medicine Technology:Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 2Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 3Pulse Systems Presents the Truth about Revenue Cycle Management Services at Practice Rx 4
... ADA,s 2009 Convention -- When Shawnae Jebbia won the Miss ... fairytale career. She appeared at events throughout the world, worked ... Shawnae,s world unexpectedly changed when she was diagnosed with hearing ... she had a difficult time understanding and accepting the sudden ...
... Oct. 29 Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... , Sales in local currency declined by 12% in ... negative currency impact. , Net earnings per diluted ... third quarter of 2008. Adjusted EPS was $1.36, a 6% ...
Cached Medicine Technology:Former Miss USA Shawnae Jebbia Shines with Siemens Pure 2Former Miss USA Shawnae Jebbia Shines with Siemens Pure 3Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 2Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 3Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 4Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 5Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 6Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 7Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 8Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 9Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 10Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 11Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 12Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 13
(Date:8/27/2014)... participation in the largest ongoing observational study of U.S. ... of the larger patient base, according to a study ... The study authors call into question the general applicability ... the use of broader enrollment criteria and existing patient ... clinical trials can be tremendously expensive and a huge ...
(Date:8/27/2014)... scientists are trying to prevent the onset of ... at Virginia Commonwealth University Massey Cancer Center are ... the process to culminate in cell death rather ... p62 protein, which is often referred to as ... disposing unwanted cellular proteins during autophagy. Results from ...
(Date:8/27/2014)... in Disability (CLD) has received a two-year, $600,000 ... of the Health Resources and Services Administration to ... aimed at improving services for children and youth ... this project, CLD worked with an Autism Advisory ... The resulting plan addresses priorities of increased awareness ...
(Date:8/27/2014)... 8/27/14)Dartmouth cancer researchers developed and tested an advanced ... interactions that contribute to disease as published yesterday ... The approach fills a gap in current analyses. ... interactions among genetic and environmental factors. When many ... versus those that reflect chance combinations among affected ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 Jaha was ... do this, Jaha invested in creating the industry’s most affordable ... adding functions that no other apps possess. Jaha ... tracker that differentiates in three simple steps: locate, challenge and ... on Tuesday, Aug 26, 2014 to garner support and to ...
Breaking Medicine News(10 mins):Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2
... National Kidney FoundationMOUNTAIN VIEW, Calif., April 20 Satellite ... of kidney dialysis services and a major sponsor of ... will be honored by the National Kidney Foundation at ... 23 at Yoshi,s Jazz Club in San Francisco. Linda ...
... 20 The managing director of Publication CONNEXION, ... speak at the 45th Annual Drug Information Association ... be present a talk entitled "Effective Publication Practices" ... is a pharmaceutical industry five-day summit uniting professionals ...
... San Diego just moved closer to unlocking the ... mode" to "specialization mode." This computational biology work ... could lead to new ideas for curbing unwanted ... Nature Genetics , could also improve our ...
... and Women,s Hospital (BWH) and the Harvard-MIT Division ... way to deliver cancer drugs directly to tumors by ... pathway and deliver a higher concentration of medication to ... April 20, in an early online edition of the ...
... - Federal stimulus package provides needed economic boost to ... April 20 House Speaker Nancy Pelosi joined ... and Family Health Center to discuss the positive impact ... communities, which granted more than $10 million in federal ...
... few signs, imaging reveals patients at much greater risk ... "Silent" heart attacks occur more often than previously believed ... death, according to a Duke University Medical Center study. ... myocardial infarctions (UMIs), often go undetected because they don,t ...
Cached Medicine News:Health News:Renal Dietitian, Linda McCann, Receives 2009 Champion of Hope Award 2Health News:How cells change gears: New insights published in Nature Genetics 2Health News:How cells change gears: New insights published in Nature Genetics 3Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 2Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 3Health News:Brigham and Women's Hospital Researchers Demonstrate a More Direct Delivery of Cancer Drugs to Tumors 4Health News:Speaker Pelosi Visits Florida Health Center 2Health News:'Silent' Heart Attacks More Common Than Thought 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: